We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Nanotube Carbon Fibers Can Rewire Damaged Hearts

By HospiMedica International staff writers
Posted on 05 Sep 2019
A new study shows that carbon nanotube fibers (CNTfs) can restore electrical conduction in the diseased myocardium, offering a potential long-term restorative solution.

Researchers at the Texas Heart Institute (THI; Houston, TX, USA), Rice University (Rice, Houston, TX, USA), and other institutions conducted open chest electrophysiology studies to examine the characteristics of CNTfs, which combine the mechanical properties of surgical suture materials and the conductive properties of metals, and their suitability as a restorative solution to impaired myocardial conduction. More...
To do so, the researchers first used radiofrequency (RF) ablation to create an epicardial conduction delay. They then sutured CNTf sutures over the conduction block.

The results revealed that in large animals (sheep), an improvement in conduction velocity using CNTf was demonstrated. In an acute rodent model, in which the CNTfs were surgically sewn across the right atrioventricular junction, ventricular pre-excitation was shown during sinus rhythm. All chronic cases demonstrated resumption of atrioventricular conduction, but these required atrial pacing. There was no gross or histopathologic evidence of toxicity. Ex-vivo electrical analysis of the CNTf-myocardial interface demonstrated contact impedance significantly lower than that of platinum iridium. The study was published on August 12, 2019, in Circulation: Arrhythmia and Electrophysiology.

“Instead of shocking and defibrillating, we are actually correcting diseased conduction of the largest major pumping chamber of the heart by creating a bridge to bypass and conduct over a scarred area of a damaged heart,” said co-lead author cardiologist Mehdi Razavi, MD, of THI. “Our experiments provided the first scientific support for using a synthetic material-based treatment rather than a drug to treat the leading cause of sudden death in the United States and many developing countries around the world.”

“Flexibility is important, because the heart is continuously pulsating and moving, so anything that’s attached to the heart’s surface is going to be deformed and flexed. Good interfacial contact is also critical to pick up and deliver the electrical signal,” said co-lead author chemical and biomolecular engineer Matteo Pasquali, PhD, of Rice. “In the past, multiple materials had to be combined to attain both electrical conductivity and effective contacts. These fibers have both properties built in by design, which greatly simplifies device construction and lowers risks of long-term failure due to delamination of multiple layers or coatings.”

CNTfs are about a quarter of the thickness of a human hair, but still contain millions of microscopic nanotubes of pure carbon. The fibers, which are soft, flexible, and tough, also exhibit low electrical impedance. As such, they show potential for many applications, including helping Parkinson's disease (PD) patients who require brain implants to treat their neurological conditions.

Related Links:
Texas Heart Institute
Rice University


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Patient Preoperative Skin Preparation
BD ChloraPrep
Hypodermic Syringe
SurTract™ Safety Syringe
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Critical Care

view channel
Image: The findings suggest that hematopoietic cell transplantation may benefit patients with Shwachman-Diamond syndrome soon after high-risk features are detected, before advanced malignancy develops. (Image Credit: Shutterstock)

Early Stem Cell Transplantation May Improve Survival in Rare Inherited Bone Marrow Disorder

Shwachman-Diamond syndrome (SDS) is a rare inherited bone marrow disorder that can progress to severe hematologic disease. More than 90% of affected children survive beyond age 20, but fewer than 30% live... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.